These data suggest OAG itself exhibited low cytotoxicity, however, could enhance the sensitivity of CML cells to IM therapy by suppressing Hh pathway and then BCR-ABL expression. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.